What are the causes and predisposing factors of Henoch‑Schönlein purpura (IgA vasculitis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes and Predisposing Factors of HSP (IgA Vasculitis)

IgA vasculitis (Henoch-Schönlein purpura) is triggered primarily by upper respiratory tract infections, with additional predisposing factors including certain vaccines, medications, and genetic susceptibility involving altered IgA1 glycosylation that leads to immune complex formation and vascular deposition.

Primary Triggers

Infections

Upper respiratory tract infections are the most common precipitating factor, occurring in approximately 21-34% of cases 1, 2. The disease shows a seasonal pattern with incidence doubling during fall and winter months, strongly suggesting environmental triggers related to respiratory pathogens 3. This infectious association is particularly prominent in pediatric cases but remains relevant in adults 4.

Vaccines and Medications

Recent evidence has identified several iatrogenic triggers 5:

  • SARS-CoV-2 and related COVID-19 vaccines
  • Human papillomavirus (HPV) vaccine
  • Certain biological agents
  • Various medications can unmask or trigger disease 6

Pathogenic Mechanisms

Immunologic Basis

The fundamental pathophysiology centers on galactose-deficient IgA1 (Gd-IgA1) formation 5, 3. This altered glycosylation exposes binding sites for autoantibodies, leading to:

  1. Formation of Gd-IgA1-containing immune complexes
  2. Perivascular deposition of IgA in small blood vessels
  3. Complement activation and neutrophil recruitment
  4. Vascular inflammation and tissue damage

An alternative mechanism involves IgA1 antibodies directed against endothelial cells, which can activate neutrophils via the IgA Fc receptor (FcαRI/CD89), inducing neutrophil migration and activation that ultimately causes tissue damage 3.

Genetic Predisposition

While specific genetic markers for IgA vasculitis are not well-defined in the provided evidence, genetics clearly plays a role in disease susceptibility 5. The altered IgA1 glycosylation pattern appears to have a genetic component, though specific alleles associated with IgA vasculitis were not detailed in the available literature.

Age-Related Differences

Important clinical caveat: Adults and children show different predisposing patterns 2:

  • Children: More commonly preceded by upper respiratory infections (21.4%), typically self-limiting course
  • Adults: Upper respiratory infections still common (34.3%), but disease tends to be more severe with higher rates of renal involvement and chronic complications

Clinical Implications

The tetrad of manifestations results from systemic immune complex deposition 4:

  • Palpable purpura (leukocytoclastic vasculitis in skin)
  • Arthralgia/arthritis
  • Gastrointestinal involvement (abdominal pain, bloody diarrhea)
  • IgA nephritis (glomerulonephritis)

Key Pitfall to Avoid

In adults, IgA vasculitis is frequently misdiagnosed initially as drug reactions, diverticulitis, or other common conditions due to overlapping presentations 6. Maintain high clinical suspicion when purpura appears following respiratory infections or new medication exposure, particularly if accompanied by abdominal pain or joint symptoms.

The disease represents a systemic hypersensitivity vasculitis where environmental triggers (primarily infections) interact with genetic susceptibility to produce abnormal IgA1 molecules that form pathogenic immune complexes 1, 3.

References

Research

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future.

Medical science monitor : international medical journal of experimental and clinical research, 2024

Research

[Immunoglobulin A vasculitis].

Innere Medizin (Heidelberg, Germany), 2024

Research

[Research advances in the etiology and pathogenesis of immunoglobulin A vasculitis].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2023

Research

Adult-onset IgA Vasculitis Initially Attributed to a Cutaneous Drug Reaction and Diverticulitis.

Journal of community hospital internal medicine perspectives, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.